About Nitec Pharma
Nitec Pharma AG is an emerging specialty pharmaceutical company headquartered in Reinach (Switzerland) with a subsidiary in Mannheim (Germany). The company's core business is the development and marketing of innovative drugs for the treatment of chronic inflammatory diseases and the resulting pain. Nitec Pharma's most advanced product is Lodotra, a circadian cytokine modulator for the treatment of rheumatoid arthritis (RA). Nitec Pharma was formed in 2004 through a spin-off from Merck KgaA and is funded by Atlas Venture, Global Life Science Ventures and NGN Capital.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Focus : Manufacturer
- Industry : Pharma
